These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19787270)

  • 1. Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responses.
    Fritz G; Issinger OG; Olsen BB
    Int J Oncol; 2009 Nov; 35(5):1151-7. PubMed ID: 19787270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks.
    Schneider CC; Hessenauer A; Götz C; Montenarh M
    Oncol Rep; 2009 Jun; 21(6):1593-7. PubMed ID: 19424641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA; Meggio F; Ruzzene M; Andrzejewska M; Kazimierczuk Z; Pinna LA
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1040-4. PubMed ID: 15358133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ATM and DNA-PK wild-type and mutant cell lines upon DSB induction in the presence and absence of CK2 inhibitors.
    Olsen BB; Fritz G; Issinger OG
    Int J Oncol; 2012 Feb; 40(2):592-8. PubMed ID: 21993375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resorufin: a lead for a new protein kinase CK2 inhibitor.
    Sandholt IS; Olsen BB; Guerra B; Issinger OG
    Anticancer Drugs; 2009 Apr; 20(4):238-48. PubMed ID: 19177021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.
    Pucko E; Ostrowski R; Matyja E
    Folia Neuropathol; 2019; 57(3):239-248. PubMed ID: 31588710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and exploitation of CK2 inhibitors.
    Sarno S; Ruzzene M; Frascella P; Pagano MA; Meggio F; Zambon A; Mazzorana M; Di Maira G; Lucchini V; Pinna LA
    Mol Cell Biochem; 2005 Jun; 274(1-2):69-76. PubMed ID: 16335530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selectivity of inhibitors of protein kinase CK2: an update.
    Pagano MA; Bain J; Kazimierczuk Z; Sarno S; Ruzzene M; Di Maira G; Elliott M; Orzeszko A; Cozza G; Meggio F; Pinna LA
    Biochem J; 2008 Nov; 415(3):353-65. PubMed ID: 18588507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.
    Duncan JS; Gyenis L; Lenehan J; Bretner M; Graves LM; Haystead TA; Litchfield DW
    Mol Cell Proteomics; 2008 Jun; 7(6):1077-88. PubMed ID: 18258654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 is dispensable for the induction of apoptosis after inhibition of protein kinase CK2.
    Schneider CC; Hessenauer A; Montenarh M; Götz C
    Prostate; 2010 Feb; 70(2):126-34. PubMed ID: 19760628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.
    Sass G; Klinger N; Sirma H; Hashemolhosseini S; Hellerbrand C; Neureiter D; Wege H; Ocker M; Tiegs G
    Int J Oncol; 2011 Aug; 39(2):433-42. PubMed ID: 21567083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
    Leung KK; Shilton BH
    Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
    Kaminska B; Ellert-Miklaszewska A; Oberbek A; Wisniewski P; Kaza B; Makowska M; Bretner M; Kazimierczuk Z
    Int J Oncol; 2009 Nov; 35(5):1091-100. PubMed ID: 19787263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific inhibitor of protein kinase CK2 delays gamma-H2Ax foci removal and reduces clonogenic survival of irradiated mammalian cells.
    Zwicker F; Ebert M; Huber PE; Debus J; Weber KJ
    Radiat Oncol; 2011 Feb; 6():15. PubMed ID: 21310046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').
    Sarno S; Reddy H; Meggio F; Ruzzene M; Davies SP; Donella-Deana A; Shugar D; Pinna LA
    FEBS Lett; 2001 May; 496(1):44-8. PubMed ID: 11343704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.
    Kramerov AA; Golub AG; Bdzhola VG; Yarmoluk SM; Ahmed K; Bretner M; Ljubimov AV
    Mol Cell Biochem; 2011 Mar; 349(1-2):125-37. PubMed ID: 21125314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
    Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Kazimierczuk Z; Grieb P; Stepien H
    Cell Tissue Res; 2010 May; 340(2):371-9. PubMed ID: 20383646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.
    Cen LP; Liu YF; Ng TK; Luo JM; van Rooijen N; Zhang M; Pang CP; Cui Q
    Exp Eye Res; 2018 Dec; 177():153-159. PubMed ID: 30118655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.
    Yde CW; Frogne T; Lykkesfeldt AE; Fichtner I; Issinger OG; Stenvang J
    Cancer Lett; 2007 Oct; 256(2):229-37. PubMed ID: 17629615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
    Dixit D; Ahmad F; Ghildiyal R; Joshi SD; Sen E
    Exp Cell Res; 2016 May; 344(1):132-142. PubMed ID: 27001465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.